References
- Sowers JR. Metabolic effect of diuretic therapy in hypertension. Intern Med Specialist 1988: 9: 133–45
- Swisloki AL, Hoffman BB, Reaven GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens 1989: 2(6 Pt 1): 419–23
- Julius S, Jamerson K, Mejia A, et al. The association of borderline hypertension with target organ changes and higher coronary risk. The Tecumseh Blood Pressure Study. JAMA 1990: 264: 354–8
- Blankenhorn DH, Nessim SA, Johnson RL, et al. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 1987: 257: 3233–40 [erratum, JAMA 1988: 259: 2698]
- Brown G, Albers JJ, Fisher LD, et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990: 323: 1289–98
- Ornish D, Brown SE, Sherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990: 336: 129–33
- Henry PD, Bentley KI. Suppression of atherosclerosis in cholesterol-fed rabbit treated with nifedipine. J Clin Invest 1981: 68: 1366–9
- Sowers J, Zemel PC, Zemel MB, et al. Hypertension and atherosclerosis: calcium antagonists as antiatherogenic agents. J Vase Med Biol 1990: 2: 1–6
- Blumlein SL, Sievers R, Kidd P, et al. Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbit. Am J Cardiol 1984: 54: 884–9
- Habib JB, Bossaller C, Wells S, et al. Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110. Circ Res 1986: 58(2): 305–9
- Lichtlen PR, Hugenholtz P, Rafflenbeul W, et al. Retardation of the progression of coronary artery disease with nifedipine: results of INTACT. (Abstr) Circulation 1989: 80(Suppl II): II382
- Waters D, Lesperance J, Francetich M, et al. A controlled clinical trial to assess the effect of a calcium antagonist upon progression of coronary atherosclerosis. (Abstr) Circulation 1989: 80(Suppl II): II266
- Schroeder JS, Gao SZ, Alderman EL, et al. Diltiazem inhibits development of early accelerated transplant coronary disease: an interim report. (Abstr) Circulation 1990: 82(Suppl III): III257